Clinical Trial Update: Study of VX-985 in Subjects With Chronic Hepatitis C [Phase 1]

View source ↗

Summary

This clinical trial update reports completion of a Phase 1 study evaluating VX-985 in subjects with chronic hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• VX-985 (VX-985)

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Chronic Hepatitis C | Phase 1 | Status: COMPLETED